Utility of ctDNA in predicting relapse in solid tumors after curative therapy: a meta-analysis

BACKGROUND: Presence of circulating tumor DNA (ctDNA) is prognostic in solid tumors treated with curative intent. Studies have evaluated ctDNA at specific “landmark” or multiple “surveillance” time points. However, variable results have led to uncertainty about its clinical validity. METHODS: A PubM...

Descripción completa

Detalles Bibliográficos
Autores principales: Mittal, Abhenil, Molto Valiente, Consolacion, Tamimi, Faris, Di Iorio, Massimo, Al-Showbaki, Laith, Cescon, David W, Amir, Eitan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Meta-Analysis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10317487/
https://www.ncbi.nlm.nih.gov/pubmed/37243731
http://dx.doi.org/10.1093/jncics/pkad040

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10317487/
https://www.ncbi.nlm.nih.gov/pubmed/37243731
http://dx.doi.org/10.1093/jncics/pkad040

Ejemplares similares